data13F

XENE – Xenon Pharmaceuticals Inc

Held by 0 of 30 tracked investors in their latest 13F filing

Investors holding0
Combined shares0
Combined reported value$0

XENE chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Stanley Druckenmiller0.00Closed0–Q3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Closed00.33
Q1 2026Stanley Druckenmiller narrow view New238,6000.47

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q1 2026Stanley Druckenmiller narrow view New238,6000.47

Reduced: reduced or closed

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Closed00.33

History

1 peakQ2 2026: 1 tracked investors
Q1 2026: 1 tracked investorsQ2 2026: 1 tracked investors
20262026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Stanley Druckenmiller–238.6K238.6K–––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).